GnRH激动剂预处理对子宫内膜异位症不孕患者IVF结局的影响:一项随机对照试验
这项单盲安慰剂对照试验纳入200例子宫内膜异位症不孕女性,比较IVF前3个月GnRHa与安慰剂的疗效。结果显示两组临床妊娠率无显著差异(25.3% vs 33.7%,P=0.212),累积活产率亦无显著差异(22.0% vs 33.7%,P=0.077)。研究组促排卵时间更长、促性腺激素总量更高、取消率更高,卵泡液睾酮水平显著更低。
要点
- IVF前3个月GnRHa预处理未显著提高子宫内膜异位症不孕患者的临床妊娠率(25.3% vs 33.7%,P=0.212)。
- 研究组促排卵时间显著更长、促性腺激素总剂量显著更高(均P<0.001),HCG日血清雌二醇显著更低(P=0.001)。
- 研究组取消周期率显著更高(P=0.042),对照组卵裂期胚胎数显著更多(P=0.023)。
核心结论
- IVF前3个月GnRHa治疗未改善子宫内膜异位症女性的临床妊娠率。
研究设计与样本
- 单盲、安慰剂对照临床试验,纳入200例子宫内膜异位症不孕女性,随机分为GnRHa组(研究组)或安慰剂组(对照组),预处理3个月后行IVF。
- 主要终点为临床妊娠率,分析临床、胚胎学结局及刺激参数;40例患者亚组检测卵泡液中雌二醇、睾酮和雄烯二酮水平,并分析卵丘和壁颗粒细胞中CYP19A1基因表达谱。
主要发现
- 研究组与对照组临床妊娠率分别为25.3%和33.7%,差异无统计学意义(P=0.212)。
- 累积活产率研究组为22.0%(95%CI 13.0至31.0),对照组为33.7%(95%CI 24.0至44.0),差异无统计学意义(P=0.077)。
- 研究组卵巢刺激时间显著更长、促性腺激素总剂量显著更高(均P<0.001),HCG日血清雌二醇水平显著更低(P=0.001)。
- 研究组取消率显著更高(P=0.042),对照组卵裂期胚胎数显著更多(P=0.023)。
- 两组壁颗粒细胞或卵丘颗粒细胞中CYP19A1基因表达及卵泡液类固醇水平无显著差异,但研究组睾酮水平显著更低(P<0.001)。
临床怎么用
- 原文结论为IVF前3个月GnRHa治疗未改善子宫内膜异位症女性的临床妊娠率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does 3-months of gonadotrophin releasing hormone agonist (GnRHa) treatment before IVF improve clinical pregnancy rate in infertile patients with endometriosis? DESIGN: Single-blind, placebo-controlled clinical trial of 200 infertile women with endometriosis assigned to use GnRHa (study group) or placebo (control group) for 3 months before IVF. Clinical, embryological outcomes and stimulation parameters were analysed. Clinical pregnancy rate was the primary endpoint. In a subgroup of 40 patients, follicular fluid levels of oestradiol, testosterone and androstendione were measured. Gene expression profile of CYP19A1 was analysed in cumulus and mural granulosa cells. RESULTS: Implantation or clinical pregnancy rate were not significantly different between the two groups. Clinical pregnancy rates were 25.3% and 33.7% in the study and control groups, respectively (P = 0.212). Cumulative live birth rate was not significantly different: 22.0% (95% CI 13.0 to 31.0) in the study group and 33.7% (95% CI 24.0 to 44.0) in the control group (P = 0.077). Ovarian stimulation was significantly longer and total dose of gonadotrophins significantly higher in the study group (both P < 0.001). Serum oestradiol levels on the day of HCG were significantly lower in the study group (P = 0.001). Cancellation rate was significantly higher in the study group (P = 0.042), whereas cleavage embryos were significantly more numerous in the control group (P = 0.023). No significant differences in the expression of CYP19A1 gene in mural or cumulus granulosa cells or steroid levels in follicular fluid between the two groups were observed, but testosterone was significantly lower in the study group (P < 0.001). CONCLUSION: Three-months of GnRHa treatment before IVF does not improve clinical pregnancy rate in women with endometriosis.
引用
- Rodríguez-Tárrega E, Monzo AM, Quiroga R, et al. Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial. Reprod Biomed Online. 2020. PMID: 32782170. doi:10.1016/j.rbmo.2020.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。